Moolec Science (MLEC) CFO details initial share and equity holdings

Rhea-AI Filing Summary

Moolec Science SA Chief Financial Officer Valeria Ines Falottico filed an initial insider ownership report listing her holdings in the company’s ordinary shares and equity awards. She directly holds 891 ordinary shares.

The filing also lists share options over 2,222 ordinary shares at an exercise price of $7.14 per share, with expiration dates in 2031, 2032, and 2033. In addition, she holds restricted share unit awards linked to 2,333 underlying ordinary shares at $14.28 per share and 2,333 underlying ordinary shares at $28.56 per share, both expiring in 2031.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Falottico Valeria Ines

(Last) (First) (Middle)

JUAN BAUTISTA ALBERDI 187, 9 FLOOR

(Street)

CABA 1426

(City) (State) (Zip)

ARGENTINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/06/2026

3. Issuer Name and Ticker or Trading Symbol
Moolec Science SA [ MLEC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	891	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Ordinary shares	02/06/2026	06/30/2031	Share Option	2,222	$7.14	D
Ordinary shares	06/30/2027	06/30/2032	Share Option	2,222	$7.14	D
Ordinary shares	06/30/2028	06/30/2033	Share Option	2,222	$7.14	D
Ordinary shares	02/06/2026	02/06/2031	Restricted Share Unit	2,333	$14.28	D
Ordinary shares	02/06/2026	02/06/2031	Restricted Share Unit	2,333	$28.56	D

Explanation of Responses:

	/s/ VALERIA FALOTTICO	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Moolec Science (MLEC) Form 3 filing show for the CFO?

The Form 3 shows CFO Valeria Ines Falottico’s initial reported holdings in Moolec Science SA. She directly owns 891 ordinary shares and holds several equity awards, including options and restricted share units tied to additional ordinary shares at specified exercise prices and expirations.

How many Moolec Science ordinary shares does the CFO directly hold?

The CFO directly holds 891 ordinary shares of Moolec Science SA. This direct holding is separate from her equity-based awards, which include share options and restricted share units that may convert into additional ordinary shares under the terms detailed in the filing.

What share options are reported for the Moolec Science CFO on Form 3?

The filing lists share options linked to 2,222 underlying ordinary shares at an exercise price of $7.14. These options have expiration dates in 2031, 2032, and 2033, reflecting multiple tranches of long-term equity incentives tied to Moolec Science’s ordinary shares.

What restricted share units does the Moolec Science CFO hold?

The CFO holds restricted share unit awards tied to 2,333 underlying ordinary shares at $14.28 and 2,333 at $28.56. Both RSU awards carry expiration dates in 2031, indicating long-term compensation aligned with Moolec Science’s ordinary share performance over several years.

Is the Moolec Science Form 3 a buy or sell transaction by the CFO?

The Form 3 does not report buy or sell transactions; it records existing holdings and awards. All listed entries are categorized as holdings, with transaction codes marked unknown and no buy or sell direction indicated in the transaction summary data.